Key Market Indicators
The Dane market for Blood and Blood Forming Organs Medicine is projected to reach $401.7 million by 2026, increasing at a 1.9% year-on-year CAGR from $356.1 million in 2021. Since 2002, the market has grown 5.3% annually. In 2021, Denmark ranked 15th, surpassed by Austria at $356.1 million. Germany, Italy and South Korea held the second, third and fourth spots, respectively. The Dane market for Anemia Prevalence is estimated to reach 3,770 hospital discharges by 2026, decreasing at a 4.2% year-on-year average rate from 4,850 hospital discharges in 2021. Since 2006, demand has dropped 4% each year. In 2021, Denmark placed 22nd, overtaken by Chile at 4,850 hospital discharges. Germany, the United Kingdom and Poland occupied the second, third and fourth positions, respectively.
